Natco Pharma Limited (NSE:NATCOPHARM) — Stock Price

Rs910.50 INR
▼ -0.67% today

Natco Pharma Limited (NSE:NATCOPHARM) is currently trading at Rs910.50 INR, down 0.67% today. Over the past 52 weeks, shares have ranged between Rs792.95 and Rs1206.00. This page tracks Natco Pharma Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Natco Pharma Limited market cap and net worth.

Natco Pharma Limited (NATCOPHARM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Natco Pharma Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Natco Pharma Limited Income Statement — Revenue, Profit & Earnings by Year

Natco Pharma Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs44.32 Billion Rs40.02 Billion Rs27.09 Billion Rs19.46 Billion Rs20.56 Billion
Cost of Revenue Rs7.27 Billion Rs7.49 Billion Rs6.54 Billion Rs5.84 Billion Rs5.32 Billion
Gross Profit Rs37.05 Billion Rs32.53 Billion Rs20.54 Billion Rs13.62 Billion Rs15.24 Billion
Research & Development Rs1.04 Billion Rs1.21 Billion Rs892.00 Million Rs1.68 Billion Rs1.43 Billion
SG&A Rs1.75 Billion Rs1.15 Billion Rs1.07 Billion Rs4.68 Billion Rs4.30 Billion
Total Operating Expenses Rs7.04 Billion Rs6.57 Billion Rs5.62 Billion Rs6.69 Billion Rs5.93 Billion
Operating Income Rs30.00 Billion Rs25.96 Billion Rs14.92 Billion Rs6.93 Billion Rs9.31 Billion
EBITDA Rs21.44 Billion Rs17.51 Billion Rs9.67 Billion Rs2.60 Billion Rs6.07 Billion
EBIT Rs19.66 Billion Rs15.71 Billion Rs8.10 Billion Rs1.23 Billion Rs4.93 Billion
Interest Expense Rs183.00 Million Rs192.00 Million Rs145.00 Million Rs177.00 Million Rs133.00 Million
Income Before Tax Rs22.91 Billion Rs16.73 Billion Rs8.62 Billion Rs2.02 Billion Rs5.80 Billion
Income Tax Expense Rs4.08 Billion Rs2.85 Billion Rs1.47 Billion Rs322.00 Million Rs1.37 Billion
Net Income Rs18.85 Billion Rs13.88 Billion Rs7.15 Billion Rs1.70 Billion Rs4.41 Billion

Natco Pharma Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Natco Pharma Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs86.31 Billion Rs69.06 Billion Rs56.57 Billion Rs51.09 Billion Rs47.92 Billion
Total Current Assets Rs52.70 Billion Rs40.23 Billion Rs30.00 Billion Rs24.97 Billion Rs23.37 Billion
Cash & Equivalents Rs539.00 Million Rs63.00 Million Rs4.14 Billion — —
Short-term Investments Rs26.88 Billion Rs17.08 Billion Rs9.93 Billion Rs6.49 Billion Rs7.92 Billion
Net Receivables Rs12.56 Billion Rs12.69 Billion Rs9.01 Billion Rs6.86 Billion Rs4.98 Billion
Inventory Rs7.66 Billion Rs7.92 Billion Rs8.09 Billion Rs8.62 Billion Rs9.10 Billion
Property, Plant & Equipment Rs26.57 Billion Rs24.35 Billion Rs23.03 Billion Rs23.08 Billion Rs22.37 Billion
Goodwill Rs574.00 Million Rs560.00 Million Rs552.00 Million Rs507.00 Million Rs0.00
Total Liabilities Rs10.19 Billion Rs10.53 Billion Rs-34.80 Billion Rs8.46 Billion Rs6.68 Billion
Total Current Liabilities Rs9.44 Billion Rs9.73 Billion Rs6.83 Billion Rs7.10 Billion Rs5.26 Billion
Long-term Debt — — — — Rs9.00 Million
Net Debt Rs-18.97 Billion Rs3.16 Billion Rs348.00 Million Rs3.21 Billion Rs2.58 Billion
Total Stockholder Equity Rs76.07 Billion Rs58.53 Billion Rs48.74 Billion Rs42.64 Billion Rs41.22 Billion
Retained Earnings Rs62.47 Billion Rs44.66 Billion Rs32.92 Billion Rs26.67 Billion Rs25.68 Billion

Natco Pharma Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Natco Pharma Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs16.97 Billion Rs12.52 Billion Rs8.49 Billion Rs465.00 Million Rs2.99 Billion
Capital Expenditures Rs4.01 Billion Rs3.59 Billion Rs2.06 Billion Rs2.43 Billion Rs2.55 Billion
Free Cash Flow Rs14.28 Billion Rs8.94 Billion Rs6.43 Billion Rs-1.96 Billion Rs442.00 Million
Investing Cash Flow Rs-14.14 Billion Rs-10.33 Billion Rs-4.77 Billion Rs-53.00 Million Rs-1.03 Billion
Financing Cash Flow Rs-2.11 Billion Rs-2.29 Billion Rs-3.63 Billion Rs348.00 Million Rs-1.86 Billion
Dividends Paid Rs-1.08 Billion Rs1.71 Billion Rs1.00 Billion Rs822.00 Million Rs1.14 Billion
Stock-Based Compensation — — Rs0.00 Rs22.00 Million Rs126.00 Million
Depreciation Rs2.35 Billion Rs1.87 Billion Rs1.64 Billion Rs1.43 Billion Rs1.17 Billion
Change in Cash Rs496.00 Million Rs8.16 Billion Rs208.00 Million Rs853.00 Million Rs60.00 Million

Natco Pharma Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Natco Pharma Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 29, 2026 — 7.69 —
Feb 12, 2026 8.46 8.67 -2.42%
Nov 14, 2025 28.94 24.56 +17.83%
Aug 12, 2025 26.84 35.79 -25.01%
May 28, 2025 22.70 34.05 -33.33%
Feb 12, 2025 7.43 13.36 -44.39%
Nov 12, 2024 37.81 31.50 +20.03%
Aug 12, 2024 37.32 42.00 -11.14%